OTCMKTS:ABCZYABCAM PLC/ADR Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ABCAM PLC/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $18.69 +0.31 (+1.67 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$18.39Now: $18.69▼$18.6950-Day Range$13.79MA: $16.65▼$19.1052-Week Range$11.26Now: $18.69▼$19.73Volume1,025 shsAverage Volume4,920 shsMarket Capitalization$3.83 billionP/E RatioN/ADividend Yield0.39%Beta1.4 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendHeadlinesSocial Media Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ABCAM PLC/ADR. Previous Next 2.0 Community Rank Outperform VotesABCAM PLC/ADR has received 87 “outperform” votes. (Add your “outperform” vote.)Underperform VotesABCAM PLC/ADR has received 136 “underperform” votes. (Add your “underperform” vote.)Community SentimentABCAM PLC/ADR has received 60.99% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ABCAM PLC/ADR and other stocks. Vote “Outperform” if you believe ABCZY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABCZY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend LeadershipABCAM PLC/ADR is a leading dividend payer. It pays a dividend yield of 0.39%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthABCAM PLC/ADR does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, ABCAM PLC/ADR will have a dividend payout ratio of 19.44 % next year. This indicates that ABCAM PLC/ADR will be able to sustain or increase its dividend. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ABCAM PLC/ADR insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ABCAM PLC/ADR are expected to grow by 16.13% in the coming year, from $0.31 to $0.36 per share. Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.03 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Industrial inorganic chemicals, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ABCZY Previous SymbolNASDAQ:ABCZY CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,100 Outstanding Shares205,080,000Market Cap$3.83 billion Next Earnings DateN/A OptionableNot Optionable OTC:ABCZY Rates by TradingView Receive ABCZY News and Ratings via Email Sign-up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter. ABCAM PLC/ADR (OTCMKTS:ABCZY) Frequently Asked Questions How has ABCAM PLC/ADR's stock been impacted by COVID-19 (Coronavirus)? ABCAM PLC/ADR's stock was trading at $14.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ABCZY shares have increased by 26.0% and is now trading at $18.6875. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of ABCAM PLC/ADR? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ABCAM PLC/ADR in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ABCAM PLC/ADR. How often does ABCAM PLC/ADR pay dividends? What is the dividend yield for ABCAM PLC/ADR? ABCAM PLC/ADR declared a Semi-Annual dividend on Tuesday, March 10th. Investors of record on Friday, March 20th will be given a dividend of $0.037 per share on Friday, May 1st. The ex-dividend date is Thursday, March 19th. View ABCAM PLC/ADR's dividend history. Has ABCAM PLC/ADR been receiving favorable news coverage? Media stories about ABCZY stock have trended negative on Saturday, InfoTrie reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. ABCAM PLC/ADR earned a media sentiment score of -2.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news aboutABCAM PLC/ADR. Who are some of ABCAM PLC/ADR's key competitors? Some companies that are related to ABCAM PLC/ADR include Merck KGaA (MKGAF), Smith & Nephew (SN), SONOVA HLDG AG/ADR (SONVY), Teva Pharmaceutical Industries (TEVA), Steris (STE), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Merck KGaA (MRK), GRIFOLS S A/S (GRFS), Hologic (HOLX), Straumann (SAUHF), Beigene (BGNE), Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), GALAPAGOS NV/S (GLPG) and EXACT Sciences (EXAS). View all competitors. Who are ABCAM PLC/ADR's key executives? ABCAM PLC/ADR's management team includes the following people: Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)James Staveley, VP of Investor RelationsMr. Nick Skinner, Sr. VP of HR What is ABCAM PLC/ADR's stock symbol? ABCAM PLC/ADR trades on the OTCMKTS under the ticker symbol "ABCZY." How do I buy shares of ABCAM PLC/ADR? Shares of ABCZY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ABCAM PLC/ADR's stock price today? One share of ABCZY stock can currently be purchased for approximately $18.69. How big of a company is ABCAM PLC/ADR? ABCAM PLC/ADR has a market capitalization of $3.83 billion. ABCAM PLC/ADR employs 1,100 workers across the globe. This page was last updated on 6/6/2020 by MarketBeat.com Staff
